These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 22684781)

  • 1. Modification of osteopontin and MMP-9 levels in patients with psoriasis on anti-TNF-α therapy.
    Buommino E; De Filippis A; Gaudiello F; Balato A; Balato N; Tufano MA; Ayala F
    Arch Dermatol Res; 2012 Aug; 304(6):481-5. PubMed ID: 22684781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective therapy with anti-TNF-alpha in patients with psoriatic arthritis is associated with decreased levels of metalloproteinases and angiogenic cytokines in the sera and skin lesions.
    Cordiali-Fei P; Trento E; D'Agosto G; Bordignon V; Mussi A; Ardigó M; Mastroianni A; Vento A; Solivetti F; Berardesca E; Ensoli F
    Ann N Y Acad Sci; 2007 Sep; 1110():578-89. PubMed ID: 17911474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adhesion of peripheral blood mononuclear cells and CD4+ T cells from patients with psoriasis to cultured endothelial cells via the interaction between lymphocyte function-associated antigen type 1 and intercellular adhesion molecule 1.
    Watabe D; Kanno H; Yoshida A; Kurose A; Akasaka T; Sawai T
    Br J Dermatol; 2007 Aug; 157(2):259-65. PubMed ID: 17596165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteopontin might be involved in bone remodelling rather than in inflammation in ankylosing spondylitis.
    Choi ST; Kim JH; Kang EJ; Lee SW; Park MC; Park YB; Lee SK
    Rheumatology (Oxford); 2008 Dec; 47(12):1775-9. PubMed ID: 18854347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resolution of endothelial activation and down-regulation of Tie2 receptor in psoriatic skin after infliximab therapy.
    Markham T; Mullan R; Golden-Mason L; Rogers S; Bresnihan B; Fitzgerald O; Fearon U; Veale DJ
    J Am Acad Dermatol; 2006 Jun; 54(6):1003-12. PubMed ID: 16713454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-18 initiates release of matrix metalloproteinase-9 from peripheral blood mononuclear cells without affecting tissue inhibitor of matrix metalloproteinases-1: suppression by TNF alpha blockage and modulation by IL-10.
    Nold M; Goede A; Eberhardt W; Pfeilschifter J; Mühl H
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Jan; 367(1):68-75. PubMed ID: 12616343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An osteopontin-NADPH oxidase signaling cascade promotes pro-matrix metalloproteinase 9 activation in aortic mesenchymal cells.
    Lai CF; Seshadri V; Huang K; Shao JS; Cai J; Vattikuti R; Schumacher A; Loewy AP; Denhardt DT; Rittling SR; Towler DA
    Circ Res; 2006 Jun; 98(12):1479-89. PubMed ID: 16709900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of the inhibitor of apoptosis protein survivin in keratinocytes and endothelial cells in psoriasis skin following infliximab therapy.
    Markham T; Mathews C; Rogers S; Mullan R; Bresnihan B; Fitzgerald O; Veale DJ; Fearon U
    Br J Dermatol; 2006 Dec; 155(6):1191-6. PubMed ID: 17107388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective assessment of body weight and body composition changes in patients with psoriasis receiving anti-TNF-α treatment.
    Renzo LD; Saraceno R; Schipani C; Rizzo M; Bianchi A; Noce A; Esposito M; Tiberti S; Chimenti S; DE Lorenzo A
    Dermatol Ther; 2011; 24(4):446-51. PubMed ID: 21910803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteopontin, CCL5 and CXCL9 are independently associated with psoriasis, regardless of the presence of obesity.
    Duarte GV; Boeira V; Correia T; Porto-Silva L; Cardoso T; Macedo MN; Oliveira MF; Carvalho E
    Cytokine; 2015 Aug; 74(2):287-92. PubMed ID: 25972108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of tissue osteopontin levels before and after different traditional therapeutic modalities in psoriatic patients.
    El-Eishi NH; Kadry D; Hegazy RA; Rashed L
    J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):351-5. PubMed ID: 22221192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GMI, a Ganoderma immunomodulatory protein, down-regulates tumor necrosis factor α-induced expression of matrix metalloproteinase 9 via NF-κB pathway in human alveolar epithelial A549 cells.
    Lin CH; Hsiao YM; Ou CC; Lin YW; Chiu YL; Lue KH; Chang JG; Ko JL
    J Agric Food Chem; 2010 Nov; 58(22):12014-21. PubMed ID: 21028821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma and tissue osteopontin in relation to plasma selenium in patients with psoriasis.
    Kadry D; Rashed L
    J Eur Acad Dermatol Venereol; 2012 Jan; 26(1):66-70. PubMed ID: 21366712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor-beta suppresses tumor necrosis factor alpha-induced matrix metalloproteinase-9 expression in monocytes.
    Vaday GG; Schor H; Rahat MA; Lahat N; Lider O
    J Leukoc Biol; 2001 Apr; 69(4):613-21. PubMed ID: 11310848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated plasma osteopontin level is associated with occurrence of psoriasis and is an unfavorable cardiovascular risk factor in patients with psoriasis.
    Chen YJ; Shen JL; Wu CY; Chang YT; Chen CM; Lee FY
    J Am Acad Dermatol; 2009 Feb; 60(2):225-30. PubMed ID: 19028408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteopontin: a new emerging role in psoriasis.
    Buommino E; Tufano MA; Balato N; Canozo N; Donnarumma M; Gallo L; Balato A; Ayala F
    Arch Dermatol Res; 2009 Jul; 301(6):397-404. PubMed ID: 19301019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A short-hairpin RNA targeting osteopontin downregulates MMP-2 and MMP-9 expressions in prostate cancer PC-3 cells.
    Liu H; Chen A; Guo F; Yuan L
    Cancer Lett; 2010 Sep; 295(1):27-37. PubMed ID: 20207476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory effects of 1alpha,25-dihydroxyvitamin D3 on inflammatory responses in psoriasis.
    Inoue M; Matsui T; Nishibu A; Nihei Y; Iwatsuki K; Kaneko F
    Eur J Dermatol; 1998; 8(1):16-20. PubMed ID: 9649661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased levels of metalloproteinase-9 and angiogenic factors in skin lesions of patients with psoriatic arthritis after therapy with anti-TNF-alpha.
    Cordiali-Fei P; Trento E; D'Agosto G; Bordignon V; Mussi A; Ardigò M; Mastroianni A; Vento A; Solivetti F; Berardesca E; Ensoli F
    J Autoimmune Dis; 2006 Oct; 3():5. PubMed ID: 17022813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor microenvironment in diffuse large B-cell lymphoma: Matrixmetalloproteinases activation is mediated by osteopontin overexpression.
    Malaponte G; Hafsi S; Polesel J; Castellano G; Spessotto P; Guarneri C; Canevari S; Signorelli SS; McCubrey JA; Libra M
    Biochim Biophys Acta; 2016 Mar; 1863(3):483-489. PubMed ID: 26381542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.